mGluR5 Facilitates Long-Term Synaptic Depression in a Stress-Induced Depressive Mouse Model
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: Glutamatergic system has been known to play a role in the pathogenesis of major depression disorder by inducing N-methyl-d-aspartate receptor-dependent long-term depression (LTD) or metabotropic glutamate receptors (mGluR)-dependent LTD. Here, we characterized the LTD in a chronic social defeat stress (CSDS)-induced depressive mouse model. Methods: CSDS was used to induce the depressive-like behaviors in C57BL/6 male mice, which were assessed using sucrose preference test and social interaction test. The synaptic strength including LTD and long-term potentiation (LTP) induced by paired-pulse low frequency stimulation (PP-LFS) was measured using whole-cell recording technique. Results: CSDS induced depressive-like behaviors and facilitated PP-LFS-induced LTD in hippocampal CA3-CA1 pathway in the susceptible mice. Interestingly, mGluR5 but not N-methyl-d-aspartate receptor mediated the PP-LFS-induced LTD. In addition, mGluR5 agonist dihydroxyphenylglycine promoted PP-LFS-induced LTD specifically in susceptible mice, which was diminished by activating the BDNF/TrkB signaling pathway. Conclusions: Our results suggest that mGluR5-dependent LTD might be responsible for the development of depressive-like behaviors in CSDS-induced depression mice model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a mouse model of chronic social defeat stress (CSDS), which causes depression, mGluR5 was shown to induce long-term depression (LTD).”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [194]
In the citing paper
“The major process responsible for synaptic plasticity is the mGluR-mediated LTD, which likely plays a significant role in the pathophysiological changes underlying depressive-like behaviors in the CSDS-induced depression paradigm. 194”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [194]
In the citing paper
“under the MDD pathological condition, due to the decreased expression of EAATs in astrocytes, excessive glutamate in the synaptic cleft activates synaptic mGluRs, which leads to neuronal excitotoxicity. 194”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [194]
Citations
Cites
Rotenstein, L. S., Ramos, M. A., Torre, M., Segal, J. B., Peluso, M. J., Guille, C., Sen, S., & Mata, D. A. (2016) · JAMA · doi:10.1001/jama.2016.17324 · Cited by 2,479
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · cited 1×
“Most efforts have been focused on developing ketamine derivatives or metabolites that are not addictive.(35) Interestingly, one of the ketamine metabolites (2S,6S;2R,6R)-hydroxynorketamine has antidepressant effect that is NMDAR independent.”
BackgroundA standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581 · cited 2×
“Historically, scientists have applied multiple forms of stressors to mice to illicit behavioral adaptations pertinent to depression.(19) These stressors include CSDS,(20) chronic unpredictable mild stress, restraint stress, or foot-shock stress followed by behavioral assessments of anhedonia such as sucrose preference…”
BackgroundMethodLong-term depression in the CNS
Collingridge, G. L., Peineau, S., Howland, J. G., & Wang, Y. T. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2867 · Cited by 926
Neurobiological mechanisms in major depressive disorder
aan het Rot, M., Mathew, S. J., & Charney, D. S. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080697 · Cited by 470 · cited 1×
“Since reserpine, a known antihypertension medication that depletes monoamines in the nerve system,(6) can cause depressive symptoms, a monoamine hypothesis proposed that depression patients probably have low levels of monoamine neurotransmitters, epinephrine and serotonin.(7,8) The tryptophan depletion studies further…”
BackgroundJesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379 · cited 1×
“Since reserpine, a known antihypertension medication that depletes monoamines in the nerve system,(6) can cause depressive symptoms, a monoamine hypothesis proposed that depression patients probably have low levels of monoamine neurotransmitters, epinephrine and serotonin.(7,8) The tryptophan depletion studies further…”
BackgroundSeverity and Variability of Depression Symptoms Predicting Suicide Attempt in High-Risk Individuals
Melhem, N. M., Porta, G., Oquendo, M. A., Zelazny, J., Keilp, J. G., Iyengar, S., Burke, A., Birmaher, B., Stanley, B., Mann, J. J., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4513 · Cited by 246 · cited 1×
“other somatic symptoms, and vegetative symptoms including sleep disorder and appetite change.(2,3) Furthermore, MDD can cause cognitive impairment and dementia.”
BackgroundIncreased cerebrospinal fluid glutamine levels in depressed patients
Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00284-x · Cited by 240 · cited 1×
“Furthermore, in recent years, an increasing body of clinical evidence has demonstrated that glutamate levels are significantly changed in the plasma and cerebrospinal fluid of patients with depression and suicide victims.(16,17) Therefore, both the ligand and the receptors in the glutamatergic system probably play key…”
BackgroundBELOZERTSEVA, I., KOS, T., POPIK, P., DANYSZ, W., & BESPALOV, A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.002 · Cited by 188 · cited 1×
“In preclinical trials, multiple mGluR antagonists have shown antidepressant-like effects.(36,37) In this study, we have shown that the mGluR5 antagonists AZD2066 and RO4917523 alleviated the depressive symptoms (Figure 5), which is consistent with our findings that mGluR-LTD is responsible for the development of depre…”
ResultEnhanced Long-Term Synaptic Depression in an Animal Model of Depression
Holderbach, R., Clark, K., Moreau, J.-L., Bischofberger, J., & Normann, C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.007 · Cited by 174 · cited 1×
“The whole-cell recordings were conducted according to previously published procedure.(21) Briefly, recordings were generated using an EPC-9 amplifier (HEKA, Lambrecht, Germany) at 20 C to 22 C.”
MethodCovington, H. E., & Miczek, K. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0190-5 · Cited by 169 · cited 1×
“These models make it possible to investigate the neurobiology of MDD across molecular, cellular, neural circuitry, and behavioral end points.(27) In the present study, we successfully developed a mice model of depression using CSDS.”
MethodLow Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder
Frye, M. A., Tsai, G. E., Huggins, T., Coyle, J. T., & Post, R. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.024 · Cited by 168 · cited 1×
“Furthermore, in recent years, an increasing body of clinical evidence has demonstrated that glutamate levels are significantly changed in the plasma and cerebrospinal fluid of patients with depression and suicide victims.(16,17) Therefore, both the ligand and the receptors in the glutamatergic system probably play key…”
BackgroundPost-SSRI Sexual Dysfunction: A Literature Review
Bala, A., Nguyen, H. M. T., & Hellstrom, W. J. G. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.07.002 · Cited by 167 · cited 1×
“More importantly, SSRI and SRNI have limited patient compliance due to some of their relatively intolerable adverse effects such as sexual dysfunction, sleep disturbances, and weight gain.(33,34) In the past decade, researchers have been committing to developing new antidepressant medications that target glutamate sys…”
BackgroundPost‐traumatic stress disorder and beyond: an overview of rodent stress models
Schöner, J., Heinz, A., Endres, M., Gertz, K., & Kronenberg, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13161 · Cited by 150 · cited 1×
“To distinguish the susceptible animals from the resistant animals, we used the so-called microdefeat as subthreshold, as previously described.(19,20) According to the microdefeat protocol, C57BL/6 mice were kept together with the CD-1 aggressor for 5 min every 15 min for three sections.”
MethodKetamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Lener, M. S., Kadriu, B., & Zarate, C. A. (2017) · Drugs · doi:10.1007/s40265-017-0702-8 · Cited by 131
Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats
RYGULA, R., ABUMARIA, N., DOMENICI, E., HIEMKE, C., & FUCHS, E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.017 · Cited by 126 · cited 1×
“For example, repeated social stressors cause a robust depressive-like behaviors featured by social avoidance and anhedonia.(26) These models make it possible to investigate the neurobiology of MDD across molecular, cellular, neural circuitry, and behavioral end points.”
BackgroundHow could stress lead to major depressive disorder?
Richter-Levin, G., & Xu, L. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.04.001 · Cited by 120
Liu, Y., Li, M., Fan, M., Song, Y., Yu, H., Zhi, X., Xiao, K., Lai, S., Zhang, J., Jin, X., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.11.025 · Cited by 106 · cited 1×
“CSDS was conducted based on previously published protocols.(18) In short, C57BL/6 mice were subjected to physical defeats that were generated by a CD-1 aggressor for 5 min every day for 10 days.”
MethodDoyère, V., Srebro, B., & Laroche, S. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.571 · Cited by 80
Neuroprogression: the hidden mechanism of depression
Labra Ruiz, N. A., Santamaría del Ángel, D., Juárez Olguín, H., & Lindoro Silva, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s177973 · Cited by 73 · cited 2×
“There are two types of synaptic plasticity: LTD and long-term potentiation (LTP) featured by long-lasting decreased or increased synaptic strength.15 Previous evidence has shown that in the depression rodent models, LTD is the major change in synaptic plasticity without obvious change in LTP.28 Consistent with previou…”
ResultNMDA Receptor Antagonists for Treatment of Depression
Ates-Alagoz, Z., & Adejare, A. (2013) · Pharmaceuticals · doi:10.3390/ph6040480 · Cited by 65 · cited 1×
“Recently, the role of NMDAR-LTD in pathogenesis of depression is under tremendous investigation due to the rapid effectiveness of NMDAR antagonist ketamine on depressive symptoms.(29) However, increasing evidence has shown that mGluR-LTD, the other major form of LTD, is also implicated in the pathogenesis of depressio…”
BackgroundAndrade, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17f11802 · Cited by 48
Domin, H., Szewczyk, B., Woźniak, M., Wawrzak-Wleciał, A., & Śmiałowska, M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.019 · Cited by 46 · cited 1×
“In preclinical trials, multiple mGluR antagonists have shown antidepressant-like effects.(36,37) In this study, we have shown that the mGluR5 antagonists AZD2066 and RO4917523 alleviated the depressive symptoms (Figure 5), which is consistent with our findings that mGluR-LTD is responsible for the development of depre…”
ResultTsunoka, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Okumura, T., Inada, T., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.04.007 · Cited by 43 · cited 1×
“In addition, association studies have identified the metabolic glutamatergic receptors as the risk factors.(13) Since long-term depression (LTD) in the hippocampus neurons has been the consistent finding in animal models with depressive-like behaviors(14) and glutamate is the most common neurotransmitter that induces…”
BackgroundRepeated treatment with reserpine as a progressive animal model of depression
Ikram, H., & Haleem, D. J. (2017) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/30/3/03.05.2017/3500/897-902 · Cited by 41
Gonzalez, J., Morales, I. S., Villarreal, D. M., & Derrick, B. E. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00941.2012 · Cited by 39
Bernard, P. B., Castano, A. M., Bayer, K. U., & Benke, T. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.04.011 · Cited by 26 · cited 1×
“However, increasing evidence has shown that mGluR-LTD, the other major form of LTD, is also implicated in the pathogenesis of depression.(30) In the present study, we showed that in our CSDS-induced depression mice model, the mGluR5 but not NMDAR facilitated the PP-LFSinduced LTD in the hippocampus CA region (Figures…”
BackgroundOptimized animal model to mimic the reality of stress-induced depression in the clinic
Zhang, Y., Wang, Y., Lei, H., Wang, L., Xue, L., Wang, X., & Zhu, X. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1335-x · Cited by 24 · cited 1×
“The level of hedonia in mice was evaluated using SPT as described previously.(24) Each mouse received the tests twice, before and after CSDS.”
MethodPharmacotherapy Effectiveness in Treating Depression After Traumatic Brain Injury: A Meta-Analysis
Slowinski, A., Coetzer, R., & Byrne, C. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18070158 · Cited by 24 · cited 1×
“Furthermore, all the monoaminebased antidepressants have limited response rate around 50% and several week delayed response.(31,32) More importantly, SSRI and SRNI have limited patient compliance due to some of their relatively intolerable adverse effects such as sexual dysfunction, sleep disturbances, and weight gain.”
BackgroundGrochtdreis, T., Brettschneider, C., Bjerregaard, F., Bleich, C., Boczor, S., Härter, M. C., Hölzel, L. P., Hüll, M., Kloppe, T., Niebling, W., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.12.007 · Cited by 24 · cited 1×
“The disability caused by MDD exerts a huge economic burden in the world.(4) According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, the criteria to diagnose MDD is five of these symptoms for 2 weeks.”
BackgroundCurrent Rapid-Onset Antidepressants and Related Animal Models
Yan, K., Chen, Y., Wu, J.-R., Li, K.-D., & Cui, Y. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180727115222 · Cited by 21 · cited 1×
“These stressors include CSDS,(20) chronic unpredictable mild stress, restraint stress, or foot-shock stress followed by behavioral assessments of anhedonia such as sucrose preference or social avoidance.(25) Affective-like behaviors are known to respond to social stressors.”
BackgroundFurukawa, T. A., Kato, T., Shinagawa, Y., Miki, K., Fujita, H., Tsujino, N., Kondo, M., Inagaki, M., & Yamada, M. (2018) · Psychological Medicine · doi:10.1017/s0033291718003331 · Cited by 17 · cited 1×
“Furthermore, all the monoaminebased antidepressants have limited response rate around 50% and several week delayed response.(31,32) More importantly, SSRI and SRNI have limited patient compliance due to some of their relatively intolerable adverse effects such as sexual dysfunction, sleep disturbances, and weight gain.”
BackgroundMitchell, A. J., Smith, A. B., Al‐Salihy, Z., Rahim, T. A., Mahmud, M. Q., & Muhyaldin, A. S. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.596477 · Cited by 11 · cited 1×
“According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, the criteria to diagnose MDD is five of these symptoms for 2 weeks.(5) The investigations into the neurobiology of MDD have focused on different neurotransmitter systems.”
MethodEvidence of ocular side effects of SSRIs and new warnings
Kirkham, J. G., & Seitz, D. P. (2016) · Evidence-Based Mental Health · doi:10.1136/eb-2016-102528 · Cited by 8
Moreno, F., Erickson, R. P., Garriock, H. A., Gelernter, J. E., Mintz, J., Oas-Terpstra, J., Davies, M. A., & Delgado, P. L. (2015) · Complex Psychiatry · doi:10.1159/000439114 · Cited by 7 · cited 1×
“The tryptophan depletion studies further modified the monoamine hypothesis which suggests low level of serotonin might be the major culprit.(9,10) In recent years, increasing evidences have suggested that glutamatergic system be implicated in the pathogenesis of depression.”
BackgroundHogenelst, K., Sarampalis, A., Leander, N. P., Müller, B. C. N., Schoevers, R. A., & Rot, M. A. H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115625156 · Cited by 3 · cited 1×
“The tryptophan depletion studies further modified the monoamine hypothesis which suggests low level of serotonin might be the major culprit.(9,10) In recent years, increasing evidences have suggested that glutamatergic system be implicated in the pathogenesis of depression.”
Background
Research works printed but not linked: 2
- Schulz PE, 2015, Continuum (Minneap Minn), 21, 756
- Ikram H, 2017, Pak J Pharm Sci, 30, 897
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“194 ATP can mediate the activity of the astrocyte-neuron network, and ATP is a signaling molecule that also controls synaptic plasticity.”
BackgroundNovel Pharmacological Approaches to the Treatment of Depression
Elias, E., Zhang, A. Y., & Manners, M. T. (2022) · Life · doi:10.3390/life12020196 · Cited by 90
Molecular and neurocircuitry mechanisms of social avoidance
Gellner, A., Voelter, J., Schmidt, U., Beins, E. C., Stein, V., Philipsen, A., & Hurlemann, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03649-x · Cited by 59
Lei, L., Wang, Y., Chen, C.-Y., Wang, Y., & Zhang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122988 · Cited by 40
Wang, W., Wang, T., Bai, S., Chen, Z., Qi, X., & Xie, P. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0731-z · Cited by 37
Metadata
- Authors
- Jiang, X., Lin, W., Cheng, Y., & Wang, D.
- Affiliations
- Qingdao Mental Health Center (CN)
- Corresponding author
- Wang, Dongming
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2019-09-16
- Volume
- 65
- Issue
- 5
- Pages
- 347-355
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- PMC
- PMC7265615
- OpenAlex
- W2974706807
- Cited by
- 18
- References
- 36
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 2
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- mGluR5, metabotropic glutamate receptors, long-term depression, chronic social defeat stress, depression, major depressive disorder, BDNF/TrkB signaling, glutamatergic system, depression-like behavior
- MeSH terms
- Animals, Humans, Male, Mice, Inbred C57BL, Long-Term Potentiation, Excitatory Amino Acid Antagonists, Excitatory Postsynaptic Potentials, Long-Term Synaptic Depression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.